Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 9/20 | 0.43 |
| ▸ | REN | P00797 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PEPD | P12955 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | HRH1 | P35367 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31146386 | 0.83 | ACE (0.41) | ACERENLMNAHSD17B10KDM4E | |
| SCHEMBL29937547 | 0.82 | ACE (0.40) | ACERENLMNAHSD17B10KDM4E | |
| SCHEMBL29801994 | 0.80 | RAB9A (0.43) | ACERENLMNAHSD17B10KDM4E | |
| SCHEMBL31515793 | 0.77 | ACE (0.38) | ACERENLMNAHSD17B10KDM4E | |
| SCHEMBL6545198 | 0.76 | KDM4E (0.40) | LMNAHSD17B10KDM4E | |
| SCHEMBL4737549 | 0.76 | ACE (0.41) | ACERENLMNAHSD17B10KDM4E | |
| SCHEMBL28789104 | 0.76 | ACE (0.41) | ACERENLMNAHSD17B10KDM4E | |
| SCHEMBL31245567 | 0.76 | ACE (0.47) | ACERENLMNAHSD17B10KDM4E | |
| SCHEMBL22436906 | 0.76 | ACE (0.47) | ACERENLMNAHSD17B10KDM4E | |
| SCHEMBL30618045 | 0.76 | ACE (0.47) | ACERENLMNAHSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3315510-B1 | MODIFIED CHEMOKINE PEPTIDE | RISE BIOPHARMACEUTICALS INC BEIJING (CN) | 2025-02-19 | — | — | EP | claimed |
| EP-4351728-A2 | METHODS OF USE OF ANTI-SORTILIN ANTIBODIES | Alector LLC (US) | 2024-04-17 | — | — | EP | disclosed |
| WO-2023220501-A1 | ACTIVATABLE THERAPEUTIC PEPTIDES AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-11-16 | — | — | WO | disclosed |
| EP-4208188-A1 | ANALOGS OF HUMAN FIBROBLAST GROWTH FACTORS | Energesis Pharmaceuticals Inc. (US) | 2023-07-12 | — | — | EP | disclosed |
| WO-2023081898-A1 | SOLUBLE CD33 AS A BIOMARKER FOR ANTI-CD33 EFFICACY | ALECTOR LLC (US) | 2023-05-11 | — | — | WO | disclosed |
| WO-2022261648-A2 | METHODS OF USE OF ANTI-SORTILIN ANTIBODIES | ALECTOR LLC (US) | 2022-12-15 | — | — | WO | disclosed |
| CN-108064248-B | Human anti-dipeptide repeat (DPR) antibodies | 生物控股有限公司 | 2022-03-15 | — | — | CN | disclosed |